About OnDosis
OnDosis is a company based in Goteborg (Sweden) founded in 2017.. OnDosis has raised $14.45 million across 4 funding rounds from investors including Astrazeneca, University of Gothenburg and European Union. OnDosis offers products and services including Dosage Manager and Connected Services. OnDosis operates in a competitive market with competitors including Lyndra, i2o Therapeutics, Biora Therapeutics, Cure Pharmaceutical and Cingulate, among others.
- Headquarter Goteborg, Sweden
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ondosis Ab
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.45 M (USD)
in 4 rounds
-
Latest Funding Round
$11.05 M (USD), Series B
May 25, 2021
-
Investors
Astrazeneca
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OnDosis
OnDosis offers a comprehensive portfolio of products and services, including Dosage Manager and Connected Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
App for individualized medicine dosing and treatment optimization.
Suite linking patients, physicians, and data for better outcomes.
Unlock access to complete
Leadership Team
2 people
Software Development Team
1 people
Sales and Marketing
1 people
Supply Team
1 people
Unlock access to complete
Funding Insights of OnDosis
OnDosis has successfully raised a total of $14.45M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $11.05 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $11.1M
-
First Round
First Round
(01 Apr 2019)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2021 | Amount | Series B - OnDosis | Valuation | Aeternum | |
| Sep, 2020 | Amount | Series A - OnDosis | Valuation |
investors |
|
| Sep, 2019 | Amount | Grant - OnDosis | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OnDosis
OnDosis has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Astrazeneca, University of Gothenburg and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Long-term value is created through active ownership in Nordic companies.
|
Founded Year | Domain | Location | |
|
VC firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OnDosis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - OnDosis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ondosis Comparisons
Competitors of OnDosis
OnDosis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lyndra, i2o Therapeutics, Biora Therapeutics, Cure Pharmaceutical and Cingulate, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Innovates long-acting oral therapies to simplify patient medication regimens.
|
|
| domain | founded_year | HQ Location |
Oral drug delivery solutions are provided via liquid technology platform.
|
|
| domain | founded_year | HQ Location |
Smart pills are developed for targeted gastrointestinal drug delivery.
|
|
| domain | founded_year | HQ Location |
Oral thin film-based drug delivery systems are developed.
|
|
| domain | founded_year | HQ Location |
Cingulate is focused on developing treatments for ADHD and anxiety.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ondosis
Frequently Asked Questions about OnDosis
When was OnDosis founded?
OnDosis was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Where is OnDosis located?
OnDosis is headquartered in Goteborg, Sweden. It is registered at Goteborg, Vastra Gotaland, Sweden.
Is OnDosis a funded company?
OnDosis is a funded company, having raised a total of $14.45M across 4 funding rounds to date. The company's 1st funding round was a Grant of $54.68K, raised on Apr 01, 2019.
What does OnDosis do?
OnDosis was founded in 2017 in Gothenburg, Sweden, within the health technology sector. Focus is placed on creating oral drug delivery systems, including the OnDosis 01 device, which enables precise, individualized dosing of oral medications in micro-unit volumes. This approach supports patients with conditions such as attention-deficithyperactivity disorder (ADHD) who face challenges in maintaining consistent medication schedules. Operations center on advancing drug administration technologies for improved patient compliance.
Who are the top competitors of OnDosis?
OnDosis's top competitors include i2o Therapeutics, Cingulate and Cure Pharmaceutical.
What products or services does OnDosis offer?
OnDosis offers Dosage Manager and Connected Services.
Who are OnDosis's investors?
OnDosis has 6 investors. Key investors include Astrazeneca, University of Gothenburg, European Union, Aeternum Capital, and DIG Investment.